+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves



Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves



Brain Research 1227: 216-220



The presence of immunoglobulin G (IgG)-type antibodies to the ganglioside, N-acetylgalactosaminyl GD1a (GalNAc-GD1a), is closely associated with the pure motor type of Guillain-Barré syndrome (GBS). In the present study, we isolated disialogangliosides from the motor neurons and motor nerves of bovine spinal cords by DEAE-Sephadex column chromatography. The disialoganglioside fraction contained GD1a, GD2, GD1b, and three gangliosides, designated X1, X2 and X3. Serum from a patient with axonal GBS with IgG anti-GalNAc-GD1a antibody yielded positive immunostaining with X1, X2, and X3. When isolated by preparative thin-layer chromatography (TLC), X1 migrated at the same position as GalNAc-GD1a from Tay-Sachs brain, suggesting that X1 is GalNAc-GD1a containing N-acetylneuraminic acid (NeuAc). TLC of isolated X2 revealed that it migrated between GD1a and GD2. On the other hand, X3 had a migratory rate on TLC between and GD1b and GT1b. Since both X2 and X3 were recognized by IgG anti-GalNAc-GD1a antibody, the results suggest that X2 is a GalNAc-GD1a species containing a mixture containing a NeuAc-and an N-glycolylneuraminic acid (NeuGc) species, and X3 is a GalNAc-GD1a species with two NeuGc. This evidence indicating the specific localization of GalNAc-GD1a and its isomers in spinal motor neurons should be useful in elucidating the pathogenic role of IgG anti-GalNAc-GD1a antibody in pure motor-type GBS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053665848

Download citation: RISBibTeXText

PMID: 18598683

DOI: 10.1016/j.brainres.2008.06.020


Related references

Acute pure motor demyelinating neuropathy with hyperreflexia and anti-GalNAc-GD1a antibodies. Clinical Neurology and Neurosurgery 114(10): 1345-1347, 2012

Rapidly progressive, predominantly motor Guillain-Barre syndrome with anti-GalNAc-GD1a antibodies. Neurology 53(9): 2122-2127, 1999

Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody. Rinsho Shinkeigaku 49(8): 488-492, 2009

Identification of glycoconjugates which are targets for anti-Gal(beta 1-3)GalNAc autoantibodies in spinal motor neurons. Journal of Neuroimmunology 34(1): 69-76, 1991

Serum IgM binding to gangliosides GalNAc-GD1a and GM2 Association with a chronic demyelinating sensory motor polyneuropathy. Neurology 54(7 Supp 3): A369, 2000

Subacute motor axonal neuropathy associated with the IgG anti-GalNAc-GD1a antibody. Bmj Case Reports 2011:, 2011

A case of chronic pure motor neuropathy associated with anti-GalNAc-GD1a-IgM antibody. No to Shinkei 55(7): 609-612, 2003

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. Journal of Neuroscience 25(7): 1620-1628, 2005

Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier. Journal of Neuroimmunology 121(1-2): 79-82, 2001

A case of chronic inflammatory demyelinating neuropathy associated with antibodies to gangliosides GM1 and GalNAc-GD1a. Rinsho Shinkeigaku 37(3): 228-232, 1997

Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Journal of Neuroimmunology 177(1-2): 201-208, 2006

Structure of the monosialyl oligosaccharides derived from sa-livary gland mucin glycoproteins of the Chinese swiftlet genus Collocalia Characterization of novel types of extended core structure, Gal1-3 1-6 GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc GalNAc. Journal of Biological Chemistry 26214: 6650-6657, 1987